These 2 Healthcare Stocks Are Set to Soar in 2024 and Beyond 

Are you looking for innovation and growth? These two healthcare stocks offer exposure to the growing tech of the healthcare industry.

| More on:

The future is aging. But it’s also changing. Technology has created more demand for innovation and growth. Meanwhile, an aging population has meant more support in the field of healthcare

The COVID-19 pandemic accelerated the digital transformation across industries, including healthcare. Telemedicine, remote patient monitoring, and digital health platforms became essential, highlighting the importance of technology in healthcare delivery. Tech companies providing infrastructure, software, and services for these transformations are seen as long-term beneficiaries.

Now, with an aging population, there is a way for investors to get in on these healthcare stocks as they continue to expand. And when it comes to this growth, these are the two I would consider first.

WELL Health

WELL Health Technologies (TSX:WELL) is a Canadian healthcare technology company that operates primary healthcare facilities and provides digital health solutions. It offers a range of telehealth services, electronic medical records (EMR) software, and patient engagement tools.

During the first quarter of 2024, WELL stock achieved record quarterly revenues of $231.6 million in the first quarter (Q1) of 2024, representing a significant increase of 37% compared to Q1 2023. This growth was driven by both acquisitions and organic growth, with a notable 13% increase organically.

Furthermore, WELL stock demonstrated improved profitability, with adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) increasing by 6% year over year to $28.3 million in Q1 2024. Additionally, WELL achieved net income of $19.6 million, compared to a loss of $10.6 million in Q1 2023. Adjusted net income was $20.2 million, marking a 43% increase from Q1 2023.

WELL stock also increased its guidance range for 2024 annual revenue to between $960 million to $980 million. Overall, it has demonstrated strong financial performance, with significant revenue growth, improved profitability, and increased free cash flow, setting up for strong long-term potential.

Andlauer

Another company to consider in this growing and improving sector is Andlauer Healthcare Group (TSX:AND). AND stock specializes in providing customized supply chain management solutions to the healthcare sector in Canada. The company focuses on transporting and managing pharmaceuticals, medical devices, and healthcare products, catering primarily to hospitals, pharmacies, clinics, and other healthcare facilities.

Now, here, investors may have to be patient, given that recent earnings demonstrated a drop on a year-over-year basis. Andlauer reported a decrease in revenue of 2.2% compared to Q1 2023, primarily driven by lower revenue in its U.S.-based truckload business and Accuristix, partially offset by organic growth in Canadian specialized transportation.

Furthermore, the company’s operating income decreased to $21.2 million from $23.7 million in Q1 2023. This decline may raise concerns about the company’s operational efficiency and profitability. Andlauer stock reported a decrease in net income to $14.9 million, or $0.35 per share (diluted), compared to $16.5 million, or $0.39 per share (diluted), in Q1 2023. Similarly, earnings per share declined by $0.04 compared to the same period last year.

Despite the decline, Andlauer stock provided insights into its future outlook, including expectations for revenue growth and operational performance. Therefore, this could be a solid long-term hold, especially for patient investors looking for a deal. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Well Health Technologies. The Motley Fool has positions in and recommends Andlauer Healthcare Group. The Motley Fool has a disclosure policy.

More on Stocks for Beginners

rising arrow with flames
Stocks for Beginners

These 2 TSX Stocks Could Triple in 5 Years

The strong long-term outlook of these two top TSX stocks could help them continue soaring in the years to come.

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

2 High-Yield Dividend ETFs to Buy to Generate Passive Income

High-yield dividend ETFs can be major winners in any portfolio, offering diversification, returns, and security. But which are the best?

Read more »

dividends grow over time
Tech Stocks

Underrated Canadian Stocks to Buy Now Before They Rally

These two Canadian stocks are ideal for those looking for a deal, while also gaining access to the burgeoning industries…

Read more »

Confused person shrugging
Dividend Stocks

Is Power Corporation of Canada Stock a Buy for Its 4.9% Dividend Yield?

Power stock is a stellar stock with long payouts, but recent dividends bring up a few questions. So is it…

Read more »

A airplane sits on a runway.
Stocks for Beginners

Up 58% in 3 Months! Is it Too Late to Invest in Air Canada?

Here’s why I expect Air Canada stock to deliver strong returns in the long run.

Read more »

cloud computing
Dividend Stocks

Is Manulife Stock a Buy for its 3.5% Dividend Yield?

Manulife stock has been a long-time dividend winner, but the average has come down over the last few years. So…

Read more »

Piggy bank in autumn leaves
Stocks for Beginners

Bank of Montreal vs. RBC: Which Canadian Bank Stock is the Better Buy?

Both of these banks have a strong reason to claim the top choice, but when it comes down to it,…

Read more »

The letters AI glowing on a circuit board processor.
Dividend Stocks

Is OpenText Stock a Buy for Its 3.6% Dividend Yield?

OpenText stock has dropped 20% in the last year, yet now the company looks incredibly valuable, especially with a 3.6%…

Read more »